Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study

Burden, A.D., Okubo, Y., Zheng, M., Thaçi, D., van de Kerkhof, P., Hu, N., Quaresma, M., Thoma, C. and Choon, S. E. (2023) Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Experimental Dermatology, 32(8), pp. 1279-1283. (doi: 10.1111/exd.14824) (PMID:37140190)

[img] Text
297834.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

Effisayil 1 was a multicentre, randomized, double‐blind, placebo‐controlled study of the anti‐interleukin (IL)‐36 receptor monoclonal antibody, spesolimab, in patients presenting with a generalized pustular psoriasis (GPP) flare. Previously published data from this study revealed that within 1 week, rapid pustular and skin clearance were observed in patients receiving spesolimab versus placebo. In this pre‐specified subgroup analysis, the efficacy of spesolimab was evaluated according to patient demographic and clinical characteristics at baseline in patients receiving spesolimab (n = 35) or placebo (n = 18) on Day 1. Efficacy was by assessed by achievement of primary endpoint (Generalized Pustular Psoriasis Physician Global Assessment [GPPGA] pustulation subscore of 0 at Week 1) and key secondary endpoint (GPPGA total score of 0 or 1 at Week 1). Safety was assessed at Week 1. Spesolimab was found to be efficacious and had a consistent and favourable safety profile in patients presenting with a GPP flare, regardless of patient demographics and clinical characteristics at baseline.

Item Type:Articles
Additional Information:The Effisayil 1 study was supported and funded by Boehringer Ingelheim.
Keywords:Autoinflammatory disorders, clinical trial, psoriasis.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Burden, Professor David
Authors: Burden, A.D., Okubo, Y., Zheng, M., Thaçi, D., van de Kerkhof, P., Hu, N., Quaresma, M., Thoma, C., and Choon, S. E.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Experimental Dermatology
Publisher:Wiley
ISSN:0906-6705
ISSN (Online):1600-0625
Published Online:04 May 2023
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in Experimental Dermatology 32(8):1279-1283
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record